KELLERMAN DONALD J (VP, Clinical Dev & Med Affairs) sold 6.6% of their position (4.01K shares) of ZOSANO PHARMA CORP on the open market
Open‑market sale worth $841.66 — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/1/2022ACC: 0001567619-22-007910
Officer· VP, Clinical Dev & Med Affairs
Since Jun 2019
-4.01K
Net shares
Net seller
$841.66
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.01K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.01K
Price / share
$0.21
Trade value
$841.66
% of position
6.6%
3/31/2022
60.34K→56.33K
Total
Net shares
−4.01K
Net value
-$841.66
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2022 | S · Sale | −4.01K | $0.21 | $841.66 | 6.6% | 60.34K | 56.33K |
| Total | −4.01K | -$841.66 | ||||||
Derivative Transactions0
No derivative transactions reported